Aim To evaluate the Limberg or rhomboid fl ap done during the past 2 years with regard to applicability, reliability and complications.Methods All Limberg fl aps done were reviewed by inspecting case records and directly following up patients. The indications, suitability, post-operative course and complications were noted.Results Eleven Limberg fl aps were done during this period. Seven patients underwent the procedure for cutaneous malignancies. Rest for various benign lesions. All the fl aps survived. One patient developed a hematoma under the fl ap. A signifi cant cosmetic defect was noted in two patients.
ConclusionThe Limberg fl ap is a safe and reliable fl ap for the coverage of various cutaneous defects if properly planned.
In this prospective, randomized study, 60 patients requiring a single sheet of graft were randomized into 2 groups. Tumescent infiltration was used for anesthesia in one group and femoral nerve block in the other. The pain during administration of anesthesia, the time required for onset of action, the pain during graft harvest and the failure rates were recorded. Statistical comparison was done using Fischers Exact probability test for the failure rates and Mann Whitney-U test for the other parameters. The pain during administration was significantly higher for tumescent infiltration. The time for onset of action was significantly faster with femoral nerve block. The pain during harvest and the failure rates did not show any significant difference. We conclude that tumescent infiltration is more painful than femoral nerve block but equally effective as anesthesia with no difference in the failure and complication rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.